If these tests indicate cancer along with the location of the original cancerous growth, the patient will be referred to a specialist who is an expert in original cancer.
This specialist will again recommend some other tests to analyze the treatment option that is likely to be the most effective. They will most probably discuss the treatment option with the multi-disciplinary team (MDT) before suggesting a treatment.
The medical tests that may be recommended as a part of the diagnostic procedure are:
Blood tests are not effective in diagnosing metastatic cancer, but they can offer a comprehensive insight about the cancer.
This implies that these tests can track whether the liver is functioning successfully, whether it is producing proteins to aid in the clotting of the blood, etc.
The imaging scans cancer specialists are most likely to recommend are CT scan and MRI scan. This is for checking the size of the cancer. At times, a positron emission tomography-CT scan or PET-CT scan may also be advised. This is a specialized scan that combines PET scan and CT scan.
It creates a three-dimensional (3D) color image to present the exact location of the cancers. In the case of secondary liver cancer, this test may be advised to track the metastasis of the disease from the bowel or melanoma.
A sample of tissue from the organ or body part that is affected by cancer is examined by a microscope for diagnosing the presence of cancer in the liver.
The healthcare practitioner collects the sample with a needle as in the case of core biopsy, or through a minor surgery called laparoscopy.
This is a procedure that determines the extent to which the cancer has metastasized.
Treatments for Secondary Liver Cancer
The treatments for this condition focus on shrinking or controlling the cancer from growing and spreading further.
The effectiveness of treatment is determined by the size and number of tumors, location of the original cancer, and the patient’s age and overall health.
The available treatment options for hepatic carcinoma are as follows: